Celldex Therapeutics market cap CLDX

Share price times shares outstanding: what the whole company sells for, since 2011.

Celldex Therapeutics is worth $2.3B at the close on Oct 23, 2026, at $29.25 a share.

That is up 29% over the last year and up 16% over five years.

Its highest close in our data was $3.3B in Aug 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$2.3B	$1.5B	$3.3B	+31%
2025	$1.8B	$1B	$2B	+4%
2024	$1.7B	$1.6B	$2.9B	−10%
2023	$1.9B	$1.1B	$2.2B	−11%
2022	$2.1B	$1B	$2.1B	+16%
2021	$1.8B	$693.6M	$2.6B	+160%
2020	$693.2M	$25M	$900.2M	+1836%
2019	$35.8M	$29.5M	$100M	+4%
2018	$34.5M	$34.5M	$414.8M	−91%
2017	$386.2M	$280.2M	$444.8M	+8%
2016	$358.4M	$310.7M	$1.3B	−77%
2015	$1.5B	$1.2B	$2.8B	−5%
2014	$1.6B	$1.1B	$2.6B	−13%
2013	$1.9B	$438.8M	$2.9B	+358%
2012	$412.8M	$137.7M	$415.2M	+260%
2011	$114.8M	$101.1M	$133.8M	n/a

Companies in Medical - Diagnostics & Research nearest Celldex Therapeutics' size, closest first, today.